Reply to D. Wu et al
- PMID: 37390374
- DOI: 10.1200/JCO.23.00887
Reply to D. Wu et al
Comment on
-
Improving Report of the ADAURA Trial by Distinguishing Treatment-Related Adverse Events From Treatment-Emergent Adverse Events and Assessing Independence of Censoring in Final Disease-Free Survival Analyses.J Clin Oncol. 2023 Sep 10;41(26):4317-4318. doi: 10.1200/JCO.23.00604. Epub 2023 Jun 30. J Clin Oncol. 2023. PMID: 37390376 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources